ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2026
[Molecular mechanisms underlying the development and spread of antibiotic resistance].
Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotics are characterized by their selective toxicity against bacterial pathogens. Due to the high genetic flexibility of bacteria, which includes mutations in their own genes as well as the uptake of foreign genes from other species, pathogens can rapidly adapt, for example, by altering molecular target structures. This article provides an overview of the molecular basis of important, clinically relevant mechanisms of resistance to antibiotics and describes the ways for transfer of the genes involved.The emergence of antibiotic-resistant mutants can be essentially explained by three fundamental molecular mechanisms: (1) alteration of the binding site for an antibiotic, (2) reduction of the antibiotic concentration at the binding site, and (3) enzymatic modification of the antibiotic. Depending on the molecular structure of the antibiotic, its interaction with the target structure, and the genetic makeup of the respective pathogen, numerous variations of these three mechanisms exist.To select an appropriate therapy in the presence of antibiotic resistance, the knowledge of the underlying resistance mechanism, the timely identification of the responsible pathogen and its susceptibility to alternative antibiotics are necessary. A fundamental disadvantage of chemically defined antibiotics is their inability to structurally adapt to conditions altered by the acquisition of resistance. In addition to reducing selective pressure and maintaining hygienic standards, the use of bacteriophages represents a promising alternative. As "biological agents," phages can adapt to phage-resistant bacterial mutants during therapy through genetic changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.